Evaluation of an Ascensia Lancing System

NACompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Diabetes
Interventions
DEVICE

Styx Lancing Device

Untrained Persons With Diabetes used the Styx Lancing Device with 28 and 30 Gauge lancets to obtain fingerstick and Alternate Site palm capillary blood. Study Staff tested the capillary blood using Contour NEXT Blood Glucose Meters (BGMs) and recorded the results. Meter results could be numeric, non-numeric (ie, error messages), or not obtained at all.

Trial Locations (1)

46544

Ascensia Diabetes Care, Mishawaka

Sponsors
All Listed Sponsors
lead

Ascensia Diabetes Care

INDUSTRY